IL28B polymorphisms, IP-10 and viral load predict virological response to therapy in chronic hepatitis C

G. Fattovich; L. Covolo; S. Bibert; G. Askarieh; M. Lagging; S. Clément; G. Malerba; M. Pasino; M. Guido; M. Puoti; G. B. Gaeta; T. Santantonio; G. Raimondo; R. Bruno; P. Y. Bochud; F. Donato; F. Negro

doi:10.1111/j.1365-2036.2011.04635.x

IL28B polymorphisms, IP-10 and viral load predict virological response to therapy in chronic hepatitis C

G. Fattovich, L. Covolo, S. Bibert, G. Askarieh, M. Lagging, S. Clément, G. Malerba, M. Pasino, M. Guido, M. Puoti, G. B. Gaeta, T. Santantonio, G. Raimondo, R. Bruno, P. Y. Bochud, F. Donato, F. Negro

IRCCS Fondazione Policlinico San Matteo

Research output: Contribution to journal › Article › peer-review

Abstract

Aliment Pharmacol Ther 2011; 33: 1162-1172 Summary Background Hepatitis C virus (HCV) is a major cause of chronic liver disease, cirrhosis and hepatocellular carcinoma and the identification of the predictors of response to antiviral therapy is an important clinical issue. Aim To determine the independent contribution of factors including IL28B polymorphisms, IFN-gamma inducible protein-10 (IP-10) levels and the homeostasis model assessment of insulin resistance (HOMA-IR) score in predicting response to therapy in chronic hepatitis C (CHC). Methods Multivariate analysis of factors predicting rapid (RVR) and sustained (SVR) virological response in 280 consecutive, treatment-naive CHC patients treated with peginterferon alpha and ribavirin in a prospective multicentre study. Results Independent predictors of RVR were HCV RNA

Original language	English
Pages (from-to)	1162-1172
Number of pages	11
Journal	Alimentary Pharmacology and Therapeutics
Volume	33
Issue number	10
DOIs	https://doi.org/10.1111/j.1365-2036.2011.04635.x
Publication status	Published - May 2011

ASJC Scopus subject areas

Pharmacology (medical)

Access to Document

10.1111/j.1365-2036.2011.04635.x

Cite this

Fattovich, G., Covolo, L., Bibert, S., Askarieh, G., Lagging, M., Clément, S., Malerba, G., Pasino, M., Guido, M., Puoti, M., Gaeta, G. B., Santantonio, T., Raimondo, G., Bruno, R., Bochud, P. Y., Donato, F., & Negro, F. (2011). IL28B polymorphisms, IP-10 and viral load predict virological response to therapy in chronic hepatitis C. Alimentary Pharmacology and Therapeutics, 33(10), 1162-1172. https://doi.org/10.1111/j.1365-2036.2011.04635.x

Fattovich, G, Covolo, L, Bibert, S, Askarieh, G, Lagging, M, Clément, S, Malerba, G, Pasino, M, Guido, M, Puoti, M, Gaeta, GB, Santantonio, T, Raimondo, G, Bruno, R, Bochud, PY, Donato, F & Negro, F 2011, 'IL28B polymorphisms, IP-10 and viral load predict virological response to therapy in chronic hepatitis C', Alimentary Pharmacology and Therapeutics, vol. 33, no. 10, pp. 1162-1172. https://doi.org/10.1111/j.1365-2036.2011.04635.x

@article{9819aa18ad4e444f8dc9459d1cd784f8,

title = "IL28B polymorphisms, IP-10 and viral load predict virological response to therapy in chronic hepatitis C",

abstract = "Aliment Pharmacol Ther 2011; 33: 1162-1172 Summary Background Hepatitis C virus (HCV) is a major cause of chronic liver disease, cirrhosis and hepatocellular carcinoma and the identification of the predictors of response to antiviral therapy is an important clinical issue. Aim To determine the independent contribution of factors including IL28B polymorphisms, IFN-gamma inducible protein-10 (IP-10) levels and the homeostasis model assessment of insulin resistance (HOMA-IR) score in predicting response to therapy in chronic hepatitis C (CHC). Methods Multivariate analysis of factors predicting rapid (RVR) and sustained (SVR) virological response in 280 consecutive, treatment-naive CHC patients treated with peginterferon alpha and ribavirin in a prospective multicentre study. Results Independent predictors of RVR were HCV RNA ",

author = "G. Fattovich and L. Covolo and S. Bibert and G. Askarieh and M. Lagging and S. Cl{\'e}ment and G. Malerba and M. Pasino and M. Guido and M. Puoti and Gaeta, {G. B.} and T. Santantonio and G. Raimondo and R. Bruno and Bochud, {P. Y.} and F. Donato and F. Negro",

year = "2011",

month = may,

doi = "10.1111/j.1365-2036.2011.04635.x",

language = "English",

volume = "33",

pages = "1162--1172",

journal = "Alimentary Pharmacology and Therapeutics",

issn = "0269-2813",

publisher = "Wiley-Blackwell Publishing Ltd",

number = "10",

}

TY - JOUR

T1 - IL28B polymorphisms, IP-10 and viral load predict virological response to therapy in chronic hepatitis C

AU - Fattovich, G.

AU - Covolo, L.

AU - Bibert, S.

AU - Askarieh, G.

AU - Lagging, M.

AU - Clément, S.

AU - Malerba, G.

AU - Pasino, M.

AU - Guido, M.

AU - Puoti, M.

AU - Gaeta, G. B.

AU - Santantonio, T.

AU - Raimondo, G.

AU - Bruno, R.

AU - Bochud, P. Y.

AU - Donato, F.

AU - Negro, F.

PY - 2011/5

Y1 - 2011/5

N2 - Aliment Pharmacol Ther 2011; 33: 1162-1172 Summary Background Hepatitis C virus (HCV) is a major cause of chronic liver disease, cirrhosis and hepatocellular carcinoma and the identification of the predictors of response to antiviral therapy is an important clinical issue. Aim To determine the independent contribution of factors including IL28B polymorphisms, IFN-gamma inducible protein-10 (IP-10) levels and the homeostasis model assessment of insulin resistance (HOMA-IR) score in predicting response to therapy in chronic hepatitis C (CHC). Methods Multivariate analysis of factors predicting rapid (RVR) and sustained (SVR) virological response in 280 consecutive, treatment-naive CHC patients treated with peginterferon alpha and ribavirin in a prospective multicentre study. Results Independent predictors of RVR were HCV RNA

AB - Aliment Pharmacol Ther 2011; 33: 1162-1172 Summary Background Hepatitis C virus (HCV) is a major cause of chronic liver disease, cirrhosis and hepatocellular carcinoma and the identification of the predictors of response to antiviral therapy is an important clinical issue. Aim To determine the independent contribution of factors including IL28B polymorphisms, IFN-gamma inducible protein-10 (IP-10) levels and the homeostasis model assessment of insulin resistance (HOMA-IR) score in predicting response to therapy in chronic hepatitis C (CHC). Methods Multivariate analysis of factors predicting rapid (RVR) and sustained (SVR) virological response in 280 consecutive, treatment-naive CHC patients treated with peginterferon alpha and ribavirin in a prospective multicentre study. Results Independent predictors of RVR were HCV RNA

UR - http://www.scopus.com/inward/record.url?scp=79954797695&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79954797695&partnerID=8YFLogxK

U2 - 10.1111/j.1365-2036.2011.04635.x

DO - 10.1111/j.1365-2036.2011.04635.x

M3 - Article

C2 - 21443535

AN - SCOPUS:79954797695

VL - 33

SP - 1162

EP - 1172

JO - Alimentary Pharmacology and Therapeutics

JF - Alimentary Pharmacology and Therapeutics

SN - 0269-2813

IS - 10

ER -

IL28B polymorphisms, IP-10 and viral load predict virological response to therapy in chronic hepatitis C

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this